95 related articles for article (PubMed ID: 16757533)
1. RET/PTC Rearrangement--a link between Hashimoto's thyroiditis and thyroid cancer...or not.
Nikiforov YE
J Clin Endocrinol Metab; 2006 Jun; 91(6):2040-2. PubMed ID: 16757533
[No Abstract] [Full Text] [Related]
2. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
3. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
[TBL] [Abstract][Full Text] [Related]
4. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
[TBL] [Abstract][Full Text] [Related]
5. 20 years of RET/PTC in thyroid cancer: clinico-pathological correlations.
Fusco A; Santoro M
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):731-5. PubMed ID: 17891236
[TBL] [Abstract][Full Text] [Related]
6. Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.
Cahill S; Smyth P; Finn SP; Denning K; Flavin R; O'Regan EM; Li J; Potratz A; Guenther SM; Henfrey R; O'Leary JJ; Sheils O
Mol Cancer; 2006 Dec; 5():70. PubMed ID: 17156473
[TBL] [Abstract][Full Text] [Related]
7. RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).
Nakazawa T; Kondo T; Kobayashi Y; Takamura N; Murata S; Kameyama K; Muramatsu A; Ito K; Kobayashi M; Katoh R
Cancer; 2005 Sep; 104(5):943-51. PubMed ID: 16015630
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.
Zhu Z; Ciampi R; Nikiforova MN; Gandhi M; Nikiforov YE
J Clin Endocrinol Metab; 2006 Sep; 91(9):3603-10. PubMed ID: 16772343
[TBL] [Abstract][Full Text] [Related]
9. Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features.
Durand S; Ferraro-Peyret C; Joufre M; Chave A; Borson-Chazot F; Selmi-Ruby S; Rousset B
Endocr Relat Cancer; 2009 Jun; 16(2):467-81. PubMed ID: 19208736
[TBL] [Abstract][Full Text] [Related]
10. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
11. [
Zhang X; Su X; Chen WC; Li Y; Yang ZY; Deng WZ; Deng TC; Yang AK
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):435-439. PubMed ID: 28635216
[No Abstract] [Full Text] [Related]
12. Papillary thyroid cancer in identical adolescent twins with osteogenesis imperfecta and Hashimoto's thyroiditis: is there a genetic link?
Diegidio P; Kolok D; Brown W; Camps JI
Am Surg; 2014 Sep; 80(9):849-50. PubMed ID: 25197868
[TBL] [Abstract][Full Text] [Related]
13. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.
Muzza M; Degl'Innocenti D; Colombo C; Perrino M; Ravasi E; Rossi S; Cirello V; Beck-Peccoz P; Borrello MG; Fugazzola L
Clin Endocrinol (Oxf); 2010 May; 72(5):702-8. PubMed ID: 20447069
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas.
Nikiforova MN; Caudill CM; Biddinger P; Nikiforov YE
Int J Surg Pathol; 2002 Jan; 10(1):15-22. PubMed ID: 11927965
[TBL] [Abstract][Full Text] [Related]
15. High frequency of level II-V lymph node involvement in RET/PTC positive papillary thyroid carcinoma.
Wang YL; Zhang RM; Luo ZW; Wu Y; Du X; Wang ZY; Zhu YX; Li DS; Ji QH
Eur J Surg Oncol; 2008 Jan; 34(1):77-81. PubMed ID: 17954023
[TBL] [Abstract][Full Text] [Related]
16. Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells.
Ameziane-El-Hassani R; Boufraqech M; Lagente-Chevallier O; Weyemi U; Talbot M; Métivier D; Courtin F; Bidart JM; El Mzibri M; Schlumberger M; Dupuy C
Cancer Res; 2010 May; 70(10):4123-32. PubMed ID: 20424115
[TBL] [Abstract][Full Text] [Related]
17. RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
Santoro M; Melillo RM; Fusco A
Eur J Endocrinol; 2006 Nov; 155(5):645-53. PubMed ID: 17062879
[TBL] [Abstract][Full Text] [Related]
18. Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.
Fulciniti F; Barizzi J; Trimboli P; Giovanella L
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659000
[TBL] [Abstract][Full Text] [Related]
19. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis.
Wirtschafter A; Schmidt R; Rosen D; Kundu N; Santoro M; Fusco A; Multhaupt H; Atkins JP; Rosen MR; Keane WM; Rothstein JL
Laryngoscope; 1997 Jan; 107(1):95-100. PubMed ID: 9001272
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population.
Kang DY; Kim KH; Kim JM; Kim SH; Kim JY; Baik HW; Kim YS
Thyroid; 2007 Nov; 17(11):1031-8. PubMed ID: 17900235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
